Ivory, a neuroscience-backed brain health platform, recently hosted Cogniverse 2026, a first-of-its-kind forum focused on preventive brain health and early detection in India.
Held in Mumbai, the event brought together over 150 Clinicians and healthcare leaders, including neurologists, psychiatrists, psychologists, neuropsychologists and geriatricians, to discuss the growing need to address cognitive decline earlier and more proactively.
Built around the idea of shifting from reactive care to preventive brain health, the forum explored how regular screening, everyday lifestyle changes, and more structured clinical approaches can play a role in maintaining cognitive health over time.
The keynote address was delivered by Dr Ratnavalli Ellajosyula, MD, DM, FAAN, Senior Consultant Neurologist and specialist in Cognitive Neurology, on “New Era of Dementia: Global Science, Local Reality”, where she highlighted the necessity of bridging the gap between global neurological advancements and specific diagnostic challenges faced in the Indian context. She emphasised that while dementia is a global crisis, local reality requires decentralised screening and early intervention models that are accessible to the aging population in India. Dr Ellajosyula is an internationally recognised expert in dementia and a pioneer in the field, having started one of India’s first memory clinics in 1998. She heads the multidisciplinary cognitive neurology clinic (CNC) at Manipal Hospitals and Annasawmy Mudaliar Hospital, Bangalore and Neurocare clinic, Mysuru.
Cogniverse 2026 spotlighted the “Brain as the Master Clock of Longevity,” demonstrating how AI-driven early detection combined with neuroplasticity can extend the human healthspan. The forum was hosted in collaboration with Dementia India Alliance, Metropolis, Agappe Diagnostics, The Wisdom Club, and The Warrier Clinic.
Dr Sumiti Saharan, Chief Scientific Officer, Ivory, said, “A large part of cognitive decline goes unnoticed until it begins to impact daily life, which limits the effectiveness of interventions. Preventive brain health requires consistent, science-backed frameworks that can be scaled across the healthcare system. Therefore, Cogniverse plays a crucial role in bringing clinicians together to build more structured, science-backed approaches that can be applied in everyday healthcare.”
Issac M. John, Co-Founder & CEO, Ivory, added, “India is ready for this conversation because of strong tailwinds in the detection of Alzheimer’s disease-modifying therapies and clear evidence that multi-modal lifestyle interventions have a tremendous impact on our healthspan. Our partnerships with several scaled players in the healthcare ecosystem also show that India is now ready to move from advocacy to active application.”
